Status:
UNKNOWN
Xpert MTB/RIF Test in the Diagnosis of Pulmonary Tuberculosis
Lead Sponsor:
Taipei Medical University WanFang Hospital
Collaborating Sponsors:
Buddhist Tzu Chi General Hospital
Chest Hospital, Ministry of Health and Welfare, Taiwan
Conditions:
Pulmonary Tuberculosis Confirmation by Culture
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
Currently in Taiwan, most clinicians use sputum smear and culture for the diagnosis of pulmonary tuberculosis (TB) and apply nucleic acid amplification (NAA) test in a selected manner. In 2013, the Wo...
Detailed Description
In this study the investigators will respect current practice in the use of NAA in the diagnosis of pulmonary TB. Clinicians may have ordered NAA as the initial diagnostic test in adults suspected of ...
Eligibility Criteria
Inclusion
- All presumptive tuberculosis cases who have sputum examinations for the diagnosis of pulmonary TB
Exclusion
- Tuberculosis cases who have been on treatment for 14 or more days who have sputum examinations for follow-up
Key Trial Info
Start Date :
June 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
6900 Patients enrolled
Trial Details
Trial ID
NCT04433195
Start Date
June 15 2020
End Date
December 31 2022
Last Update
May 12 2022
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang-Hua Hospital
Chang-hua, Taiwan, 513
2
Buddhist Tzu Chi General Hospital
Hualien City, Taiwan
3
Taichung Veterans General Hospital
Taichung, Taiwan
4
Chest Hospital, Ministry of Health and Welfare
Tainan, Taiwan, 717